BIOMARIN PHARMACEUTICAL INC Research and Development Expense
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Research and Development Expense of $206.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC research and development expense for the quarter ending 2026-06-30 was $206.95M, a 28.30% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC research and development expense for the quarter ending 2026-03-31 was $178.80M, a 12.64% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC research and development expense for the quarter ending 2025-12-31 was $192.41M, a 10.90% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC research and development expense for the quarter ending 2025-09-30 was $409.48M, a 121.46% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC research and development expense for fiscal 2025 was $921.93M, a 23.39% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC research and development expense for fiscal 2024 was $747.18M, a 0.06% increase from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC research and development expense for fiscal 2023 was $746.77M, a 14.96% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC research and development expense for fiscal 2022 was $649.61M, a 3.31% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $206.95M 10-Q · filed 2026-08-06 | $385.75M 10-Q · filed 2026-08-06 | $578.16M derived: sum of 3 quarters · filed 2026-08-06 | $987.64M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $178.80M 10-Q · filed 2026-05-05 | $371.21M derived: sum of 2 quarters · filed 2026-05-05 | $780.69M derived: sum of 3 quarters · filed 2026-05-05 | $942.00M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $192.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $601.89M derived: sum of 2 quarters · filed 2026-02-26 | $763.20M derived: sum of 3 quarters · filed 2026-08-06 | $921.93M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $409.48M 10-Q · filed 2025-10-28 | $570.79M derived: sum of 2 quarters · filed 2026-08-06 | $729.52M 10-Q · filed 2025-10-28 | $903.03M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $161.31M 10-Q · filed 2026-08-06 | $320.04M 10-Q · filed 2026-08-06 | $493.55M derived: sum of 3 quarters · filed 2026-08-06 | $678.45M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $158.73M 10-Q · filed 2026-05-05 | $332.24M derived: sum of 2 quarters · filed 2026-05-05 | $517.14M derived: sum of 3 quarters · filed 2026-05-05 | $700.93M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $173.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $358.41M derived: sum of 2 quarters · filed 2026-02-26 | $542.20M derived: sum of 3 quarters · filed 2026-02-26 | $747.18M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $184.90M 10-Q · filed 2025-10-28 | $368.69M derived: sum of 2 quarters · filed 2025-10-28 | $573.67M 10-Q · filed 2025-10-28 | $779.92M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $183.79M 10-Q · filed 2025-08-05 | $388.77M 10-Q · filed 2025-08-05 | $595.02M derived: sum of 3 quarters · filed 2026-02-26 | $786.34M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $204.99M 10-Q · filed 2025-05-02 | $411.24M derived: sum of 2 quarters · filed 2026-02-26 | $602.55M derived: sum of 3 quarters · filed 2026-02-26 | $779.91M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $206.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $397.56M derived: sum of 2 quarters · filed 2026-02-26 | $574.93M derived: sum of 3 quarters · filed 2026-02-26 | $746.77M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $191.31M 10-Q · filed 2024-10-31 | $368.68M derived: sum of 2 quarters · filed 2024-10-31 | $540.52M 10-Q · filed 2024-10-31 | $713.27M derived: sum of 4 quarters · filed 2025-02-24 | |
| 2023-06-30 | $177.36M 10-Q · filed 2024-08-05 | $349.21M 10-Q · filed 2024-08-05 | $521.96M derived: sum of 3 quarters · filed 2025-02-24 | $679.79M derived: sum of 4 quarters · filed 2025-02-24 | |
| 2023-03-31 | $171.85M 10-Q · filed 2024-04-26 | $344.60M derived: sum of 2 quarters · filed 2025-02-24 | $502.43M derived: sum of 3 quarters · filed 2025-02-24 | $660.62M derived: sum of 4 quarters · filed 2025-02-24 | |
| 2022-12-31 | $172.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $330.58M derived: sum of 2 quarters · filed 2025-02-24 | $488.77M derived: sum of 3 quarters · filed 2025-02-24 | $649.61M 10-K · filed 2025-02-24 | |
| 2022-09-30 | $157.83M 10-Q · filed 2023-11-02 | $316.02M derived: sum of 2 quarters · filed 2023-11-02 | $476.86M 10-Q · filed 2023-11-02 | $637.95M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2022-06-30 | $158.19M 10-Q · filed 2023-08-02 | $319.03M 10-Q · filed 2023-08-02 | $480.12M derived: sum of 3 quarters · filed 2024-02-26 | $637.99M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2022-03-31 | $160.84M 10-Q · filed 2023-04-28 | $321.93M derived: sum of 2 quarters · filed 2024-02-26 | $479.80M derived: sum of 3 quarters · filed 2024-02-26 | $640.90M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2021-12-31 | $161.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $318.96M derived: sum of 2 quarters · filed 2024-02-26 | $480.07M derived: sum of 3 quarters · filed 2024-02-26 | $628.79M 10-K · filed 2024-02-26 | |
| 2021-09-30 | $157.87M 10-Q · filed 2022-10-28 | $318.98M derived: sum of 2 quarters · filed 2022-10-28 | $467.70M 10-Q · filed 2022-10-28 | $624.37M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | $161.11M 10-Q · filed 2022-08-04 | $309.83M 10-Q · filed 2022-08-04 | $466.50M derived: sum of 3 quarters · filed 2023-02-27 | $613.55M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | $148.72M 10-Q · filed 2022-04-29 | $305.39M derived: sum of 2 quarters · filed 2023-02-27 | $452.44M derived: sum of 3 quarters · filed 2023-02-27 | $634.58M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | $156.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $303.72M derived: sum of 2 quarters · filed 2023-02-27 | $485.86M derived: sum of 3 quarters · filed 2023-02-27 | $628.12M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $147.05M 10-Q · filed 2021-10-29 | $329.19M derived: sum of 2 quarters · filed 2021-10-29 | $471.45M 10-Q · filed 2021-10-29 | $644.26M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | $182.14M 10-Q · filed 2021-07-30 | $324.40M 10-Q · filed 2021-07-30 | $497.21M derived: sum of 3 quarters · filed 2022-02-25 | $670.17M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $142.26M 10-Q · filed 2021-04-30 | $315.07M derived: sum of 2 quarters · filed 2022-02-25 | $488.03M derived: sum of 3 quarters · filed 2022-02-25 | $673.67M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $172.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $345.77M derived: sum of 2 quarters · filed 2022-02-25 | $531.42M derived: sum of 3 quarters · filed 2022-02-25 | $715.01M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $172.96M 10-Q · filed 2020-11-06 | $358.60M derived: sum of 2 quarters · filed 2020-11-06 | $542.20M 10-Q · filed 2020-11-06 | $717.59M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | $185.64M 10-Q · filed 2020-08-05 | $369.23M 10-Q · filed 2020-08-05 | $544.62M derived: sum of 3 quarters · filed 2021-02-26 | $706.03M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | $183.59M 10-Q · filed 2020-05-01 | $358.98M derived: sum of 2 quarters · filed 2021-02-26 | $520.39M derived: sum of 3 quarters · filed 2021-02-26 | $695.97M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $175.39M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $336.80M derived: sum of 2 quarters · filed 2021-02-26 | $512.38M derived: sum of 3 quarters · filed 2021-02-26 | $696.33M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $161.41M 10-Q/A · filed 2019-11-04 | $336.99M derived: sum of 2 quarters · filed 2019-11-04 | $520.94M 10-Q/A · filed 2019-11-04 | $689.55M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $175.58M 10-Q · filed 2019-08-02 | $359.53M 10-Q · filed 2019-08-02 | $528.14M derived: sum of 3 quarters · filed 2020-02-27 | $682.24M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $183.95M 10-Q · filed 2019-04-29 | $352.56M derived: sum of 2 quarters · filed 2020-02-27 | $506.66M derived: sum of 3 quarters · filed 2020-02-27 | $649.70M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $168.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $322.71M derived: sum of 2 quarters · filed 2020-02-27 | $465.75M derived: sum of 3 quarters · filed 2020-02-27 | $610.75M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $154.10M 10-Q · filed 2018-10-26 | $297.14M derived: sum of 2 quarters · filed 2018-10-26 | $442.14M 10-Q · filed 2018-10-26 | $617.39M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | $143.04M 10-Q · filed 2018-08-03 | $288.04M 10-Q · filed 2018-08-03 | $463.28M derived: sum of 3 quarters · filed 2019-02-28 | $624.12M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-03-31 | $145.00M 10-Q · filed 2018-04-27 | $320.25M derived: sum of 2 quarters · filed 2019-02-28 | $481.08M derived: sum of 3 quarters · filed 2019-02-28 | $648.12M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2016-12-31 | $175.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $336.07M derived: sum of 2 quarters · filed 2019-02-28 | $503.11M derived: sum of 3 quarters · filed 2019-02-28 | $661.90M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $160.83M 10-Q · filed 2017-10-31 | $327.87M derived: sum of 2 quarters · filed 2017-10-31 | $486.66M 10-Q · filed 2017-10-31 | $662.78M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-06-30 | $167.04M 10-Q · filed 2017-08-02 | $325.83M 10-Q · filed 2017-08-02 | $501.95M derived: sum of 3 quarters · filed 2018-02-26 | $660.66M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-03-31 | $158.79M 10-Q · filed 2017-05-04 | $334.91M derived: sum of 2 quarters · filed 2018-02-26 | $493.62M derived: sum of 3 quarters · filed 2018-02-26 | $651.52M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2015-12-31 | $176.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $334.83M derived: sum of 2 quarters · filed 2018-02-26 | $492.73M derived: sum of 3 quarters · filed 2018-02-26 | $634.81M 10-K · filed 2018-02-26 | |
| 2015-09-30 | $158.71M 10-Q · filed 2016-11-03 | $316.61M derived: sum of 2 quarters · filed 2016-11-03 | $458.69M 10-Q · filed 2016-11-03 | $600.75M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-06-30 | $157.90M 10-Q · filed 2016-08-08 | $299.98M 10-Q · filed 2016-08-08 | $442.04M derived: sum of 3 quarters · filed 2017-02-27 | $567.73M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-03-31 | $142.07M 10-Q · filed 2016-05-02 | $284.14M derived: sum of 2 quarters · filed 2017-02-27 | $409.83M derived: sum of 3 quarters · filed 2017-02-27 | $517.53M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2014-12-31 | $142.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $267.75M derived: sum of 2 quarters · filed 2017-02-27 | $375.45M derived: sum of 3 quarters · filed 2017-02-27 | $461.54M 10-K · filed 2017-02-27 | |
| 2014-09-30 | $125.69M 10-Q · filed 2015-11-02 | $233.39M derived: sum of 2 quarters · filed 2015-11-02 | $319.48M 10-Q · filed 2015-11-02 | $319.55M 10-Q · filed 2014-10-28 | $416.87M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $107.70M 10-Q · filed 2015-08-05 | $193.87M 10-Q · filed 2015-08-05 | $291.18M derived: sum of 3 quarters · filed 2016-02-29 | $379.24M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $86.17M 10-Q · filed 2015-05-05 | $183.48M derived: sum of 2 quarters · filed 2016-02-29 | $271.54M derived: sum of 3 quarters · filed 2016-02-29 | $357.20M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $97.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $185.38M derived: sum of 2 quarters · filed 2016-02-29 | $271.04M derived: sum of 3 quarters · filed 2016-02-29 | $354.78M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $88.06M 10-Q · filed 2014-10-28 | $173.72M derived: sum of 2 quarters · filed 2014-10-28 | $257.47M 10-Q · filed 2014-10-28 | $341.83M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-06-30 | $85.66M 10-Q · filed 2014-07-31 | $169.40M 10-Q · filed 2014-07-31 | $253.77M derived: sum of 3 quarters · filed 2015-03-02 | $319.98M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-03-31 | $83.74M 10-Q · filed 2014-05-02 | $168.11M derived: sum of 2 quarters · filed 2015-03-02 | $234.31M derived: sum of 3 quarters · filed 2015-03-02 | $312.13M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2012-12-31 | $84.36M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $150.57M derived: sum of 2 quarters · filed 2015-03-02 | $228.38M derived: sum of 3 quarters · filed 2015-03-02 | $302.22M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $66.21M 10-Q · filed 2013-10-28 | $144.02M derived: sum of 2 quarters · filed 2013-10-28 | $217.85M 10-Q · filed 2013-10-28 | $275.76M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2012-06-30 | $77.81M 10-Q · filed 2013-07-29 | $151.65M 10-Q · filed 2013-07-29 | $209.55M derived: sum of 3 quarters · filed 2014-02-26 | $268.13M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2012-03-31 | $73.83M 10-Q · filed 2013-04-29 | $131.74M derived: sum of 2 quarters · filed 2014-02-26 | $190.32M derived: sum of 3 quarters · filed 2014-02-26 | $243.23M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2011-12-31 | $57.91M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $116.48M derived: sum of 2 quarters · filed 2014-02-26 | $169.39M derived: sum of 3 quarters · filed 2014-02-26 | $214.37M 10-K · filed 2014-02-26 | |
| 2011-09-30 | $58.58M 10-Q · filed 2012-10-29 | $111.49M derived: sum of 2 quarters · filed 2012-10-29 | $156.47M 10-Q · filed 2012-10-29 | $198.70M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-06-30 | $52.91M 10-Q · filed 2012-08-02 | $97.89M 10-Q · filed 2012-08-02 | $140.12M derived: sum of 3 quarters · filed 2013-02-26 | $179.49M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-03-31 | $45.02M 10-Q · filed 2012-04-30 | $87.21M derived: sum of 2 quarters · filed 2013-02-26 | $126.58M derived: sum of 3 quarters · filed 2013-02-26 | $162.23M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2010-12-31 | $42.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $81.56M derived: sum of 2 quarters · filed 2013-02-26 | $117.21M derived: sum of 3 quarters · filed 2013-02-26 | $147.31M 10-K · filed 2013-02-26 | |
| 2010-09-30 | $39.37M 10-Q · filed 2011-10-31 | $75.02M derived: sum of 2 quarters · filed 2011-10-31 | $105.11M 10-Q · filed 2011-10-31 | $132.56M derived: sum of 4 quarters · filed 2012-02-22 | |
| 2010-06-30 | $35.65M 10-Q · filed 2011-08-01 | $65.75M 10-Q · filed 2011-08-01 | $93.19M derived: sum of 3 quarters · filed 2012-02-22 | $120.18M derived: sum of 4 quarters · filed 2012-02-22 | |
| 2010-03-31 | $30.10M 10-Q · filed 2011-04-29 | $57.54M derived: sum of 2 quarters · filed 2012-02-22 | $84.53M derived: sum of 3 quarters · filed 2012-02-22 | $110.86M derived: sum of 4 quarters · filed 2012-02-22 | |
| 2009-12-31 | $27.44M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $54.43M derived: sum of 2 quarters · filed 2012-02-22 | $80.76M derived: sum of 3 quarters · filed 2012-02-22 | $115.12M 10-K · filed 2012-02-22 | |
| 2009-09-30 | $26.99M 10-Q · filed 2010-10-29 | $53.31M derived: sum of 2 quarters · filed 2010-10-29 | $87.67M 10-Q · filed 2010-10-29 | ||
| 2009-06-30 | $26.32M 10-Q · filed 2010-08-04 | $60.68M 10-Q · filed 2010-08-04 | |||
| 2009-03-31 | $8.80M 10-K · filed 2012-02-22 | ||||
| 2008-12-31 | $93.29M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |